Amarantus Bioscience Holdings Inc (AMBS)

[michelebucks]

We will update the marketplace regarding our diagnostic assets and plans for their continued development in the near future.

In closing, the future has never looked brighter for Amarantus. We have unambiguous data supporting MANF’s further development in our lead Parkinson’s disease indication, we now have rights to seven diagnostic blood tests in significant markets, and our MANF asset continues to make progress in secondary indications. We are looking forward to an exciting 2013 for the Company and its shareholders.

I thank you for taking the time to read this letter and looking forward to communicating with you in the future.

Sincerely,

Gerald E. Commissiong

President & Chief Executive Officer

Gonna pick up another 200k shares right now! Getting ready for the big run on great news.